Symbol:
Sytl2
Name:
synaptotagmin-like 2
RGD ID:
1307647
Description:
Predicted to enable neurexin family protein binding activity; phosphatase binding activity; and phospholipid binding activity. Predicted to be involved in positive regulation of mucus secretion and vesicle docking involved in exocytosis. Predicted to act upstream of or within protein localization to plasma membrane. Predicted to be located in melanosome and membrane. Predicted to be active in exocytic vesicle and plasma membrane. Orthologous to human SYTL2 (synaptotagmin like 2); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene; acrylamide.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC361604; MGC189337; synaptotagmin-like protein 2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 153,685,403 - 153,791,758 (+) NCBI GRCr8 mRatBN7.2 1 144,272,870 - 144,379,310 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 144,273,360 - 144,379,222 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 152,196,100 - 152,302,039 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 159,372,674 - 159,480,256 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 152,246,593 - 152,354,171 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 156,334,298 - 156,440,327 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 1 154,536,592 - 154,599,515 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 154,579,949 - 154,599,430 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 156,335,279 - 156,354,353 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 160,800,567 - 160,863,654 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 146,977,959 - 147,084,664 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 1 142,493,600 - 142,599,739 (+) NCBI Celera Cytogenetic Map 1 q32 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Sytl2 Rat 1,2-dimethylhydrazine decreases expression ISO Sytl2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SYTL2 mRNA CTD PMID:22206623 Sytl2 Rat 17alpha-ethynylestradiol affects expression ISO Sytl2 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of SYTL2 mRNA CTD PMID:17555576 Sytl2 Rat 17beta-estradiol multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SYTL2 mRNA and EGF protein inhibits the reaction [Estradiol results in decreased expression of SYTL2 mRNA] CTD PMID:24758408 and PMID:30165855 Sytl2 Rat 17beta-estradiol decreases expression ISO Sytl2 (Mus musculus) 6480464 Estradiol results in decreased expression of SYTL2 mRNA CTD PMID:39298647 Sytl2 Rat 17beta-estradiol decreases expression ISO SYTL2 (Homo sapiens) 6480464 Estradiol results in decreased expression of SYTL2 mRNA CTD PMID:24758408 Sytl2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SYTL2 mRNA CTD PMID:22298810 and PMID:34747641 Sytl2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SYTL2 mRNA CTD PMID:33387578 Sytl2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO SYTL2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of SYTL2 mRNA CTD PMID:22298810 Sytl2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Sytl2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SYTL2 mRNA CTD PMID:19770486 and PMID:25270620 Sytl2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Sytl2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SYTL2 mRNA CTD PMID:21570461 Sytl2 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of SYTL2 mRNA CTD PMID:21346803 Sytl2 Rat 2-hydroxypropanoic acid decreases expression ISO SYTL2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of SYTL2 mRNA CTD PMID:30851411 Sytl2 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Sytl2 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of SYTL2 mRNA CTD PMID:25172293 Sytl2 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SYTL2 mRNA CTD PMID:28628672 Sytl2 Rat 4,4'-diaminodiphenylmethane increases expression ISO Sytl2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of SYTL2 mRNA CTD PMID:18648102 Sytl2 Rat 4,4'-sulfonyldiphenol decreases expression ISO SYTL2 (Homo sapiens) 6480464 bisphenol S results in decreased expression of SYTL2 mRNA CTD PMID:25912373 Sytl2 Rat 4,4'-sulfonyldiphenol decreases methylation ISO SYTL2 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of SYTL2 gene CTD PMID:31601247 Sytl2 Rat 4,4'-sulfonyldiphenol decreases expression ISO Sytl2 (Mus musculus) 6480464 bisphenol S results in decreased expression of SYTL2 mRNA CTD PMID:39298647 Sytl2 Rat 4,4'-sulfonyldiphenol increases expression ISO Sytl2 (Mus musculus) 6480464 bisphenol S results in increased expression of SYTL2 mRNA CTD PMID:30951980 Sytl2 Rat 5-fluorouracil increases expression ISO SYTL2 (Homo sapiens) 6480464 Fluorouracil results in increased expression of SYTL2 mRNA CTD PMID:16510598 Sytl2 Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SYTL2 mRNA CTD PMID:28959563 Sytl2 Rat aflatoxin B1 increases methylation ISO SYTL2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SYTL2 gene CTD PMID:27153756 Sytl2 Rat aflatoxin B1 increases expression ISO SYTL2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of SYTL2 mRNA CTD PMID:27153756 Sytl2 Rat Aflatoxin B2 alpha increases methylation ISO SYTL2 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of SYTL2 intron CTD PMID:30157460 Sytl2 Rat all-trans-retinoic acid increases expression ISO SYTL2 (Homo sapiens) 6480464 Tretinoin results in increased expression of SYTL2 mRNA CTD PMID:23830798 Sytl2 Rat all-trans-retinoic acid multiple interactions ISO Sytl2 (Mus musculus) 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of SYTL2 mRNA and [bisphenol F co-treated with Tretinoin] results in decreased expression of SYTL2 mRNA CTD PMID:30951980 Sytl2 Rat antirheumatic drug increases expression ISO SYTL2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of SYTL2 mRNA CTD PMID:24449571 Sytl2 Rat aristolochic acid A decreases expression ISO SYTL2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SYTL2 mRNA CTD PMID:33212167 Sytl2 Rat arsane multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SYTL2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SYTL2 mRNA CTD PMID:32525701 and PMID:39836092 Sytl2 Rat arsenic atom multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SYTL2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SYTL2 mRNA CTD PMID:32525701 and PMID:39836092 Sytl2 Rat benzo[a]pyrene decreases expression ISO Sytl2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SYTL2 mRNA CTD PMID:22228805 Sytl2 Rat benzo[a]pyrene increases expression ISO SYTL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of SYTL2 mRNA CTD PMID:32234424 Sytl2 Rat benzo[a]pyrene increases methylation ISO SYTL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SYTL2 promoter CTD PMID:27901495 Sytl2 Rat benzo[a]pyrene affects methylation ISO SYTL2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SYTL2 5' UTR CTD PMID:27901495 Sytl2 Rat benzo[a]pyrene decreases expression ISO SYTL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SYTL2 mRNA CTD PMID:22316170 Sytl2 Rat benzo[a]pyrene increases expression ISO Sytl2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SYTL2 mRNA CTD PMID:19770486 Sytl2 Rat bis(2-ethylhexyl) phthalate increases expression ISO SYTL2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of SYTL2 mRNA CTD PMID:31163220 Sytl2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SYTL2 mRNA CTD PMID:25181051 Sytl2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SYTL2 mRNA CTD PMID:36779543 Sytl2 Rat bisphenol A multiple interactions ISO Sytl2 (Mus musculus) 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of SYTL2 mRNA CTD PMID:30951980 Sytl2 Rat bisphenol A increases expression ISO Sytl2 (Mus musculus) 6480464 bisphenol A results in increased expression of SYTL2 mRNA CTD PMID:30951980 Sytl2 Rat bisphenol A affects methylation ISO Sytl2 (Mus musculus) 6480464 bisphenol A affects the methylation of SYTL2 promoter CTD PMID:27334623 Sytl2 Rat bisphenol A multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SYTL2 mRNA CTD PMID:28628672 Sytl2 Rat bisphenol F increases expression ISO Sytl2 (Mus musculus) 6480464 bisphenol F results in increased expression of SYTL2 mRNA CTD PMID:30951980 Sytl2 Rat bisphenol F multiple interactions ISO Sytl2 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of SYTL2 mRNA CTD PMID:30951980 Sytl2 Rat carbamazepine affects expression ISO SYTL2 (Homo sapiens) 6480464 Carbamazepine affects the expression of SYTL2 mRNA CTD PMID:25979313 Sytl2 Rat carbon nanotube decreases expression ISO Sytl2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Sytl2 Rat CGP 52608 multiple interactions ISO SYTL2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SYTL2 gene] CTD PMID:28238834 Sytl2 Rat chlorpyrifos increases expression ISO Sytl2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SYTL2 mRNA CTD PMID:37019170 Sytl2 Rat choline multiple interactions ISO Sytl2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SYTL2 mRNA CTD PMID:20938992 Sytl2 Rat coumestrol decreases expression ISO SYTL2 (Homo sapiens) 6480464 Coumestrol results in decreased expression of SYTL2 mRNA CTD PMID:19167446 Sytl2 Rat coumestrol multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 Sytl2 Rat crocidolite asbestos decreases expression ISO SYTL2 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of SYTL2 mRNA CTD PMID:29523930 Sytl2 Rat cyclosporin A decreases expression ISO SYTL2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SYTL2 mRNA CTD PMID:27989131 Sytl2 Rat cytarabine increases expression ISO SYTL2 (Homo sapiens) 6480464 Cytarabine results in increased expression of SYTL2 mRNA CTD PMID:21198554 Sytl2 Rat dexamethasone multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SYTL2 mRNA CTD PMID:28628672 Sytl2 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SYTL2 mRNA CTD PMID:21266533 Sytl2 Rat dibutyl phthalate increases expression ISO Sytl2 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of SYTL2 mRNA CTD PMID:17361019 and PMID:21266533 Sytl2 Rat dioxygen increases expression ISO SYTL2 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of SYTL2 mRNA CTD PMID:26516004 Sytl2 Rat dioxygen multiple interactions ISO Sytl2 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SYTL2 mRNA CTD PMID:30529165 Sytl2 Rat diuron decreases expression ISO SYTL2 (Homo sapiens) 6480464 Diuron results in decreased expression of SYTL2 mRNA CTD PMID:35967413 Sytl2 Rat dorsomorphin multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Sytl2 Rat endosulfan affects expression EXP 6480464 Endosulfan affects the expression of SYTL2 mRNA CTD PMID:29391264 Sytl2 Rat Enterolactone multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYTL2 mRNA CTD PMID:19167446 Sytl2 Rat entinostat decreases expression ISO SYTL2 (Homo sapiens) 6480464 entinostat results in decreased expression of SYTL2 mRNA CTD PMID:26272509 Sytl2 Rat entinostat multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYTL2 mRNA CTD PMID:27188386 Sytl2 Rat folic acid multiple interactions ISO Sytl2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SYTL2 mRNA CTD PMID:20938992 Sytl2 Rat folic acid decreases expression ISO Sytl2 (Mus musculus) 6480464 Folic Acid results in decreased expression of SYTL2 mRNA CTD PMID:25629700 Sytl2 Rat FR900359 affects phosphorylation ISO SYTL2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of SYTL2 protein CTD PMID:37730182 Sytl2 Rat fulvestrant increases methylation ISO SYTL2 (Homo sapiens) 6480464 Fulvestrant results in increased methylation of SYTL2 gene CTD PMID:31601247 Sytl2 Rat genistein increases expression ISO Sytl2 (Mus musculus) 6480464 Genistein results in increased expression of SYTL2 mRNA CTD PMID:32186404 Sytl2 Rat hydrogen peroxide affects expression ISO SYTL2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SYTL2 mRNA CTD PMID:20044591 Sytl2 Rat indometacin multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SYTL2 mRNA CTD PMID:28628672 Sytl2 Rat ketamine increases expression EXP 6480464 Ketamine results in increased expression of SYTL2 mRNA CTD PMID:20080153 Sytl2 Rat L-methionine multiple interactions ISO Sytl2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SYTL2 mRNA CTD PMID:20938992 Sytl2 Rat leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of SYTL2 mRNA CTD PMID:24136188 Sytl2 Rat methylmercury chloride decreases expression ISO SYTL2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SYTL2 mRNA CTD PMID:23179753 more ... Sytl2 Rat methylmercury chloride multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYTL2 mRNA CTD PMID:27188386 Sytl2 Rat mitoxantrone affects response to substance ISO SYTL2 (Homo sapiens) 6480464 SYTL2 mRNA affects the susceptibility to Mitoxantrone CTD PMID:16044152 Sytl2 Rat N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SYTL2 mRNA CTD PMID:28801915 Sytl2 Rat nickel sulfate decreases expression ISO SYTL2 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of SYTL2 mRNA CTD PMID:22714537 Sytl2 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SYTL2 mRNA CTD PMID:25729387 Sytl2 Rat panobinostat multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYTL2 mRNA CTD PMID:27188386 Sytl2 Rat paracetamol increases expression ISO SYTL2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SYTL2 mRNA CTD PMID:22230336 Sytl2 Rat paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SYTL2 mRNA CTD PMID:33387578 Sytl2 Rat PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 Sytl2 Rat perfluorohexanesulfonic acid decreases expression ISO SYTL2 (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in decreased expression of SYTL2 mRNA CTD PMID:25812627 Sytl2 Rat perfluorononanoic acid decreases expression ISO SYTL2 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of SYTL2 mRNA CTD PMID:25812627 Sytl2 Rat perfluorooctane-1-sulfonic acid decreases expression ISO SYTL2 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of SYTL2 mRNA CTD PMID:25812627 Sytl2 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Sytl2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SYTL2 mRNA CTD PMID:36331819 Sytl2 Rat perfluorooctanoic acid decreases expression ISO SYTL2 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of SYTL2 mRNA CTD PMID:25812627 Sytl2 Rat propanal increases expression ISO SYTL2 (Homo sapiens) 6480464 propionaldehyde results in increased expression of SYTL2 mRNA CTD PMID:26079696 Sytl2 Rat rac-lactic acid decreases expression ISO SYTL2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of SYTL2 mRNA CTD PMID:30851411 Sytl2 Rat resveratrol multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of SYTL2 mRNA CTD PMID:19167446 Sytl2 Rat rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SYTL2 mRNA CTD PMID:28374803 Sytl2 Rat SB 431542 multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Sytl2 Rat sodium arsenate multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SYTL2 mRNA CTD PMID:32525701 Sytl2 Rat sodium arsenite increases expression ISO SYTL2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SYTL2 mRNA CTD PMID:29301061 and PMID:38568856 Sytl2 Rat sodium arsenite decreases expression ISO Sytl2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SYTL2 mRNA CTD PMID:36209798 Sytl2 Rat sodium arsenite multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SYTL2 mRNA CTD PMID:39836092 Sytl2 Rat sodium arsenite decreases expression ISO SYTL2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SYTL2 mRNA CTD PMID:34032870 Sytl2 Rat sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of SYTL2 mRNA CTD PMID:25993096 Sytl2 Rat sotorasib multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYTL2 mRNA CTD PMID:36139627 Sytl2 Rat sunitinib decreases expression ISO SYTL2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of SYTL2 mRNA CTD PMID:31533062 Sytl2 Rat tamoxifen affects expression ISO Sytl2 (Mus musculus) 6480464 Tamoxifen affects the expression of SYTL2 mRNA CTD PMID:17555576 Sytl2 Rat temozolomide decreases expression ISO SYTL2 (Homo sapiens) 6480464 Temozolomide results in decreased expression of SYTL2 mRNA CTD PMID:31758290 Sytl2 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SYTL2 mRNA CTD PMID:30723492 and PMID:31150632 Sytl2 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SYTL2 mRNA CTD PMID:23411599 Sytl2 Rat thiram increases expression ISO SYTL2 (Homo sapiens) 6480464 Thiram results in increased expression of SYTL2 mRNA CTD PMID:38568856 Sytl2 Rat titanium dioxide affects expression ISO Sytl2 (Mus musculus) 6480464 titanium dioxide affects the expression of SYTL2 mRNA CTD PMID:17656681 Sytl2 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SYTL2 mRNA CTD PMID:25729387 Sytl2 Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of SYTL2 mRNA CTD PMID:25729387 Sytl2 Rat trametinib multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYTL2 mRNA CTD PMID:36139627 Sytl2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SYTL2 mRNA CTD PMID:33387578 Sytl2 Rat trichostatin A decreases expression ISO SYTL2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of SYTL2 mRNA CTD PMID:24935251 and PMID:26272509 Sytl2 Rat trichostatin A multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYTL2 mRNA CTD PMID:27188386 Sytl2 Rat triclosan decreases expression ISO SYTL2 (Homo sapiens) 6480464 Triclosan results in decreased expression of SYTL2 mRNA CTD PMID:30510588 Sytl2 Rat triphenyl phosphate affects expression ISO SYTL2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of SYTL2 mRNA CTD PMID:37042841 Sytl2 Rat valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of SYTL2 mRNA CTD PMID:24136188 Sytl2 Rat valproic acid decreases expression ISO SYTL2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SYTL2 mRNA CTD PMID:23179753 more ... Sytl2 Rat valproic acid multiple interactions ISO SYTL2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYTL2 mRNA CTD PMID:27188386 Sytl2 Rat vancomycin decreases expression ISO Sytl2 (Mus musculus) 6480464 Vancomycin results in decreased expression of SYTL2 mRNA CTD PMID:18930951 Sytl2 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SYTL2 mRNA CTD PMID:23034163 Sytl2 Rat zoledronic acid decreases expression ISO SYTL2 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of SYTL2 mRNA CTD PMID:24714768
1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 2-hydroxypropanoic acid (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (ISO) 5-fluorouracil (ISO) acrylamide (EXP) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) antirheumatic drug (ISO) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) carbamazepine (ISO) carbon nanotube (ISO) CGP 52608 (ISO) chlorpyrifos (ISO) choline (ISO) coumestrol (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) cytarabine (ISO) dexamethasone (ISO) dibutyl phthalate (EXP,ISO) dioxygen (ISO) diuron (ISO) dorsomorphin (ISO) endosulfan (EXP) Enterolactone (ISO) entinostat (ISO) folic acid (ISO) FR900359 (ISO) fulvestrant (ISO) genistein (ISO) hydrogen peroxide (ISO) indometacin (ISO) ketamine (EXP) L-methionine (ISO) leflunomide (EXP) methylmercury chloride (ISO) mitoxantrone (ISO) N-methyl-4-phenylpyridinium (EXP) nickel sulfate (ISO) oxaliplatin (EXP) panobinostat (ISO) paracetamol (EXP,ISO) PCB138 (EXP) perfluorohexanesulfonic acid (ISO) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (ISO) propanal (ISO) rac-lactic acid (ISO) resveratrol (ISO) rotenone (EXP) SB 431542 (ISO) sodium arsenate (ISO) sodium arsenite (ISO) sodium dichromate (EXP) sotorasib (ISO) sunitinib (ISO) tamoxifen (ISO) temozolomide (ISO) tetrachloromethane (EXP) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) topotecan (EXP) trametinib (ISO) trichloroethene (EXP) trichostatin A (ISO) triclosan (ISO) triphenyl phosphate (ISO) valdecoxib (EXP) valproic acid (ISO) vancomycin (ISO) vinclozolin (EXP) zoledronic acid (ISO)
Sytl2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 153,685,403 - 153,791,758 (+) NCBI GRCr8 mRatBN7.2 1 144,272,870 - 144,379,310 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 144,273,360 - 144,379,222 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 152,196,100 - 152,302,039 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 159,372,674 - 159,480,256 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 152,246,593 - 152,354,171 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 156,334,298 - 156,440,327 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 1 154,536,592 - 154,599,515 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 154,579,949 - 154,599,430 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 156,335,279 - 156,354,353 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 160,800,567 - 160,863,654 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 146,977,959 - 147,084,664 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 1 142,493,600 - 142,599,739 (+) NCBI Celera Cytogenetic Map 1 q32 NCBI
SYTL2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 11 85,694,229 - 85,854,870 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 11 85,694,224 - 85,811,159 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 11 85,405,272 - 85,565,913 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 11 85,082,912 - 85,146,692 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 11 85,082,914 - 85,107,859 NCBI Celera 11 82,714,568 - 82,831,481 (-) NCBI Celera Cytogenetic Map 11 q14.1 NCBI HuRef 11 81,702,610 - 81,819,526 (-) NCBI HuRef CHM1_1 11 85,290,075 - 85,406,976 (-) NCBI CHM1_1 T2T-CHM13v2.0 11 85,630,917 - 85,791,555 (-) NCBI T2T-CHM13v2.0
Sytl2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 7 89,951,421 - 90,059,927 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 7 89,951,460 - 90,059,927 (+) Ensembl GRCm39 Ensembl GRCm38 7 90,302,211 - 90,410,719 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 7 90,302,252 - 90,410,719 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 7 97,497,209 - 97,558,949 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 7 90,223,891 - 90,285,897 (+) NCBI MGSCv36 mm8 Celera 7 87,675,751 - 87,737,560 (+) NCBI Celera Cytogenetic Map 7 E1 NCBI cM Map 7 50.54 NCBI
Sytl2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955414 7,104,268 - 7,174,001 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955414 7,104,239 - 7,172,791 (+) NCBI ChiLan1.0 ChiLan1.0
SYTL2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 9 86,616,996 - 86,773,315 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 11 87,664,954 - 87,823,384 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 11 80,749,861 - 80,866,479 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 11 84,358,095 - 84,474,422 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 11 84,358,155 - 84,421,509 (-) Ensembl panpan1.1 panPan2
SYTL2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 21 13,639,054 - 13,756,332 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 21 13,688,338 - 13,755,414 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 21 13,505,757 - 13,623,017 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 21 13,819,767 - 13,937,016 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 21 13,819,798 - 13,937,013 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 21 13,608,437 - 13,725,706 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 21 13,680,690 - 13,797,966 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 21 13,733,418 - 13,850,744 (+) NCBI UU_Cfam_GSD_1.0
Sytl2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404947 71,978,205 - 72,082,188 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936498 13,577,795 - 13,681,808 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936498 13,577,839 - 13,681,782 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SYTL2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 9 19,617,293 - 19,734,633 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 9 19,617,287 - 19,763,439 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 9 21,887,423 - 22,023,108 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SYTL2 (Chlorocebus sabaeus - green monkey)
Sytl2 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 507 Count of miRNA genes: 222 Interacting mature miRNAs: 283 Transcripts: ENSRNOT00000042163, ENSRNOT00000045048 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
61442 Strs1 Sensitivity to stroke QTL 1 7.4 cerebrum integrity trait (VT:0010549) post-insult time to onset of cerebrovascular lesion (CMO:0002343) 1 121767634 166767634 Rat 1578780 Cm52 Cardiac mass QTL 52 3.3 0.0001 heart mass (VT:0007028) heart wet weight (CMO:0000069) 1 81591954 219808434 Rat 1578654 Bss10 Bone structure and strength QTL 10 4 femur morphology trait (VT:0000559) femoral neck cortical cross-sectional area (CMO:0001702) 1 49393172 159356837 Rat 2302378 Insul11 Insulin level QTL 11 3.25 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 1 144267353 251128347 Rat 1598866 Bp287 Blood pressure QTL 287 5.1 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 121006655 166006655 Rat 1578770 Stresp23 Stress response QTL 23 kidney sympathetic nerve activity (VT:0004050) stimulated renal sympathetic nerve activity to basal renal sympathetic nerve activity ratio (CMO:0001786) 1 123350408 182418476 Rat 9590300 Scort16 Serum corticosterone level QTL 16 4.39 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 1 103111621 148111621 Rat 70160 Bw18 Body weight QTL 18 5.7 body mass (VT:0001259) body weight (CMO:0000012) 1 144267353 196383668 Rat 2298545 Neuinf8 Neuroinflammation QTL 8 4.6 nervous system integrity trait (VT:0010566) spinal cord beta-2 microglobulin mRNA level (CMO:0002125) 1 57336763 151090257 Rat 7794788 Mcs32 Mammary carcinoma susceptibility QTL 32 2.61 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 1 115540693 238914717 Rat 631199 Cm23 Cardiac mass QTL 23 4.6 0.0004 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 1 115585465 172949803 Rat 1598850 Bp297 Blood pressure QTL 297 2.1 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 121006655 166006655 Rat 152025235 Bw194 Body weight QTL 194 4.86 body mass (VT:0001259) 1 123556856 242907031 Rat 1598853 Memor3 Memory QTL 3 4.5 exploratory behavior trait (VT:0010471) total horizontal distance resulting from voluntary locomotion in an experimental apparatus (CMO:0001443) 1 143506580 212458660 Rat 152025232 Bw192 Body weight QTL 192 3.93 body mass (VT:0001259) 1 117917486 196963478 Rat 724521 Uae1 Urinary albumin excretion QTL 1 3.8 0.0001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 90508614 173018436 Rat 1358902 Bw47 Body weight QTL 47 1.67 body mass (VT:0001259) body weight (CMO:0000012) 1 90508614 180359386 Rat 61348 Bp30 Blood pressure QTL 30 2.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 144017057 197814409 Rat 8655649 Arrd1 Age-related retinal degeneration QTL 1 4.89 retinal layer morphology trait (VT:0003727) percentage of study population developing retinopathy during a period of time (CMO:0002453) 1 100357752 183970443 Rat 2317833 Alcrsp19 Alcohol response QTL 19 12.4 0.001 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 1 100979852 145979852 Rat 731168 Bp154 Blood pressure QTL 154 3.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 94642644 214537671 Rat 631202 Gluco13 Glucose level QTL 13 0.0001 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 131763437 159756369 Rat 631205 Bp196 Blood pressure QTL 196 4 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 118944897 199050459 Rat 1300158 Bp173 Blood pressure QTL 173 3.48 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 1 115540693 185145286 Rat 631206 Niddm40 Non-insulin dependent diabetes mellitus QTL 40 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 1 136745990 163747690 Rat 737828 Hcas3 Hepatocarcinoma susceptibility QTL 3 4.9 liver integrity trait (VT:0010547) liver tumorous lesion volume to total liver volume ratio (CMO:0001082) 1 144267353 222987745 Rat 1641897 Alcrsp1 Alcohol response QTL 1 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 1 100979852 145979852 Rat 1331749 Hrtrt11 Heart rate QTL 11 2.973 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 1 94494440 198211706 Rat 1331751 Bp199 Blood pressure QTL 199 3.60022 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 1 94494440 181830018 Rat 9685799 Bp375 Blood pressure QTL 375 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 125611501 170611501 Rat 2293140 Bp313 Blood pressure QTL 313 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 121833674 166833674 Rat 9685802 Bp376 Blood pressure QTL 376 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 126540680 171540680 Rat 724529 Cm16 Cardiac mass QTL 16 2.7 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 1 87580395 150700247 Rat 61370 Mcs3 Mammary carcinoma susceptibility QTL 3 2.15 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 1 102268556 147268556 Rat 1641895 Bp298 Blood pressure QTL 298 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 123350408 182418476 Rat 70209 Niddm23 Non-insulin dependent diabetes mellitus QTL 23 2.82 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 94494440 198324465 Rat 631496 Bp97 Blood pressure QTL 97 3.08 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 106047847 151047847 Rat 634315 Niddm45 Non-insulin dependent diabetes mellitus QTL 45 7.16 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 1 144267916 172949660 Rat 634314 Niddm44 Non-insulin dependent diabetes mellitus QTL 44 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 49393289 199050459 Rat 61379 Bp44 Blood pressure QTL 44 19.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 144267916 174133260 Rat 2303591 Gluco41 Glucose level QTL 41 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 102168504 147168504 Rat 1331793 Bp200 Blood pressure QTL 200 3.71601 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 94494440 172949803 Rat 2313060 Bss71 Bone structure and strength QTL 71 2.6 0.0001 long bone metaphysis morphology trait (VT:0000133) tibia midshaft total cross-sectional area (CMO:0001715) 1 118944747 163944747 Rat 6893347 Bw98 Body weight QTL 98 0.2 0.53 body mass (VT:0001259) body weight (CMO:0000012) 1 133680936 178680936 Rat 1354591 Cm36 Cardiac mass QTL 36 4.1 heart left ventricle mass (VT:0007031) calculated heart weight (CMO:0000073) 1 102813953 201278233 Rat 724550 Thym3 Thymus enlargement QTL 3 7.82 0.001 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 1 136829932 181829932 Rat 7421630 Bp362 Blood pressure QTL 362 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 118608292 241799120 Rat 71118 Thym1 Thymus enlargement QTL 1 10.17 0.001 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 1 136829932 181829932 Rat 70225 Bp58 Blood pressure QTL 58 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 32356093 162846471 Rat 10059597 Bp377 Blood pressure QTL 377 3.42 0.025 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 32737458 199368955 Rat 631519 Pia11 Pristane induced arthritis QTL 11 5.3 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 1 136830018 181830018 Rat 6893361 Bw104 Body weight QTL 104 0.59 0.27 body mass (VT:0001259) body weight (CMO:0000012) 1 133680936 178680936 Rat 738006 Anxrr14 Anxiety related response QTL 14 4 0.00035 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 1 130636910 175636910 Rat 1558645 Bw55 Body weight QTL 55 3.2 0.004 body mass (VT:0001259) body weight (CMO:0000012) 1 133680936 178680936 Rat 1354615 Cm32 Cardiac mass QTL 32 5.2 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 1 102813953 201278233 Rat 634348 Bp138 Blood pressure QTL 138 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 125611501 168883176 Rat 8694370 Bw154 Body weight QTL 154 8.91 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 1 103111621 148111621 Rat 738028 Anxrr12 Anxiety related response QTL 12 4.9 0.00001 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 1 130636910 175636910 Rat 1354623 Rf46 Renal function QTL 46 3.8 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 1 102813953 151162766 Rat 631654 Bp107 Blood pressure QTL 107 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 125611501 170611501 Rat 631544 Bp84 Blood pressure QTL 84 5.6 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 123350408 181759564 Rat 152025212 Bw190 Body weight QTL 190 5.7 body mass (VT:0001259) 1 123556856 196963478 Rat 631549 Bp89 Blood pressure QTL 89 5.7 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 123350581 201284552 Rat 1358189 Cstrr1 Cold stress response QTL 1 0.0001 catecholamine amount (VT:0010543) urine norepinephrine level (CMO:0001629) 1 123350408 182418476 Rat 1354606 Bp246 Blood pressure QTL 246 3.6 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 102813953 218753816 Rat
D1Mit21
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 144,314,913 - 144,315,053 (+) MAPPER mRatBN7.2 mRatBN7.2 1 144,314,913 - 144,315,053 (-) MAPPER mRatBN7.2 Rnor_6.0 1 154,535,070 - 154,535,209 NCBI Rnor6.0 Rnor_6.0 1 156,399,063 - 156,399,202 NCBI Rnor6.0 Rnor_5.0 1 162,645,185 - 162,645,324 UniSTS Rnor5.0 Rnor_5.0 1 160,799,045 - 160,799,184 UniSTS Rnor5.0 RGSC_v3.4 1 147,020,341 - 147,020,480 UniSTS RGSC3.4 RGSC_v3.4 1 147,020,340 - 147,020,480 RGD RGSC3.4 RGSC_v3.1 1 147,098,747 - 147,098,886 RGD Celera 1 142,535,144 - 142,535,283 UniSTS RH 3.4 Map 1 1125.8 RGD RH 3.4 Map 1 1125.8 UniSTS Cytogenetic Map 1 q32 UniSTS
RH140314
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 144,378,823 - 144,378,964 (+) MAPPER mRatBN7.2 mRatBN7.2 1 144,378,823 - 144,378,964 (-) MAPPER mRatBN7.2 Rnor_6.0 1 156,334,640 - 156,334,780 NCBI Rnor6.0 Rnor_6.0 1 154,599,033 - 154,599,173 NCBI Rnor6.0 Rnor_5.0 1 160,863,008 - 160,863,148 UniSTS Rnor5.0 Rnor_5.0 1 162,580,762 - 162,580,902 UniSTS Rnor5.0 RGSC_v3.4 1 147,084,260 - 147,084,400 UniSTS RGSC3.4 Celera 1 142,599,257 - 142,599,397 UniSTS RH 3.4 Map 1 1129.0 UniSTS Cytogenetic Map 1 q32 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
17
11
56
147
125
123
77
31
77
12
280
122
115
56
80
46
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000042163 ⟹ ENSRNOP00000039142
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 1 156,335,279 - 156,354,353 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000045048 ⟹ ENSRNOP00000048585
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 144,362,125 - 144,379,222 (+) Ensembl Rnor_6.0 Ensembl 1 154,579,949 - 154,599,430 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000103814 ⟹ ENSRNOP00000077270
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 144,273,360 - 144,379,221 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000114461 ⟹ ENSRNOP00000096638
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 144,273,360 - 144,379,221 (+) Ensembl
RefSeq Acc Id:
NM_001108492 ⟹ NP_001101962
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,886 - 153,791,758 (+) NCBI mRatBN7.2 1 144,273,360 - 144,379,224 (+) NCBI
RefSeq Acc Id:
XM_008759651 ⟹ XP_008757873
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,406 - 153,791,758 (+) NCBI mRatBN7.2 1 144,272,872 - 144,379,310 (+) NCBI Rnor_6.0 1 156,334,298 - 156,440,326 (-) NCBI
Sequence:
GGCGAGCCCTGTGCTCCGGGAAGGTCCTGCGCTGCCCTCCCCTCCGCCCTCCCCAAACAGCAGCGGGTGACACCTGGGCGGCGCAACAGGCTGCCAGCGCCGGGCGGCAGAGAGAGGCTGGCAGCTCC AAGGAGGTCGAGGATGCACCAAGGAGTCTGCTGCTCAAGATGGTGATGAGCATGGAGAGAGACTGTGTCTAAGACAGGTCCAGAGAGGGTGCACTGAAGAAATTCTGCTGAAGGCGTATACAAGGCAT GCAGCATCCTCCTGAGACCTGTTCATCCCATAGACCACTGCTACCTCAAGGAACCTTGCTCTTATGATTTTGATGTCATCTGCCTAAAACTTTTGTGGATTCCAGTCAAGACTTTTACTACCAAATAA GATACCATTTAATTTTGCATCCTGTAATCATCCTGGCTGTGGTCTCAGCTCTTTTTCCCTGAGAACCTCAAGCTACATTTGTTTGTTACAATTGTTCCTTTTGTGTAAATTGTGCTCCAAAATGATCG ACTTAAGTTTCCTGACAGAGGAGGAACAAGATGCCATCTTAAAGGTTCTGCAGAGGGATGCTGCCCTGAAGAGGGCTGAAGAGGAGAGGGTCAGACACTTGCCTGAAAAAATTAAGGATGACCAACAA CTAAAGAACATGAGTGGCCAATGGTTTTATGAAGCTAAGGCAAAAAGACACAAGGACAAAATCCATGGTGCTGACATCATCAGAGCATCCATGAGAAGGAAGAGACTCCCAGCGGCAGCTGAGCAGAA GAAGGACACAGCAATGAGGACAAAGGAGAGCTGGGTGAATAATGTCAACAAAGACGCTTCCCTTCCCCCAGAGCTAGCTGTTGTGGAAGAGCCAGCAGATGACACAGGTCCAGCAGGCCCAAGTTCCA GTGTGGTGGATCCAGCTTCCAGTGCGATTGAAAGGTCCCAGGAAAATACGAGGACTCCAGCTGTGTCTCTGCCCAAGCAAAGGAAGAATCCATTCGACAGCCTCGAGACGCCAGAAGATCTCTCATCG CAACAAACCAAAACCAAGCAGTCAAAAACTGGAAAAGCTGGTTTATTTCAGATTTCAAAAGAGGGTGGGTTGTCAGAATCAAAAGAAAAGCCATCTATTCCAGATATGTCATGTCAAAAGTCAGAGAA ACCAAAGCAACCTGTATCCATGGAGACAGAAAATGCGTCTCTTATCAAAGCTCCAATCCCCAAAGCCAGAAAACTGATCTACAAATCAAATGACTTAAAGAACGACGATTACCTGTCTTTTGCTGGAC AAAGGAGGGACTCCCTGAATGCGAGAGGGACTCCAAGAGGGATCCTAAAGCGCAACTCCAGTTCCAGTAGCACGGACTCAGAGACTCTCCGTTTAAATTACAACTTGGATCCGAAAAGCAAAATCCTA TCACCTGGCCTCACCATCCATGAGAGAATTTCTGAAAAGGAACATTCTTTAGATGATGACTCTTGCACAAACTCACTTGAGCCCTTAAAGCATGTGAGATTCTCTGCCGTGAAGAATGACCTTCCACA GAGTCCTAGACCTGTCCTTGGCCAGGAAGTAGGAGAATTTACTGTTTTAGAATCTGACAGGTTGCAAAATGGAACTGAAGATACAGGGGACATAGATGAGTTTCAGGATCACCCAGAGTTCTCCCACA GAAAACCTTTGTCTCTTTATCAGTCAGTGACAAACCCAAGAATTTCGGAAAGGGAAACAGAACAGCCGATGTCTTCTGGGTCTATTCCAAGTGAGGAGATCTCTTGCCATTCAGACATTCTACCCACA AGACCTCAGTGTGTGGAGAGTTCATCCATCATCAGTGAACAAGATAAATCATCACATTTTACAAAGCTTCAATCAGAAATGTCCAAAAGCCCTGAGGATGAACTGACTCAGTGTGTTGAGCCTGAGCC ATCCCAGACATCAGACCACAGTTTTAGAGACCATCGGCAAGGTAAGCCTCTTCTCACGGCTCTCACTGATCAGACAGCCTCACCCGTGGGTCCATGTGCTACAGAGATAAGGAAGACAACTGATGATT CCATATCTAAAGTCCTAGACTGGTTTAATCGAAGTTCTCATACAGAGGACAGTACATCAACTCTCCAACATCTTCAAGGACTAGATCTCAGAGAGCAAACAGACTCGAGAGCACAGATTAGCAATACC TTGATGACAGACAACATGTCTCTGAAGGGAGACGACACAAAGGTCCCAGCATCCACTACAACTAAGGTGAAGCCTGTGAGGCCTGACTCAACATTTCAAGAAGAGGGAGATGTGCTGGCTTCTGAAAG TTGCCGAGACAGTGACGCACTTCTCAAGTCTAACTCTGAGGATTTGTCCCAACAAGGCACCCTCAAGAAAGGTCCAGATACACTGCAACGATTTGAAAGATACAGAATCCCAAGTCACAAGAATGAAA ACATGGGTGATAGCCAAGGTTCAGAGAGTACAGGAGAAGGAGTTGGGACCCTTCCTGCAGACAGTGACTACCTGCTCAGACCTCTGAAAAGATCTGATTCAGAGGAAGCCCCATGGAACACTACGCAT CCCAGCAGCTTAGGTAAAGGGAAAACCAAGTTCCATGTACCTCAAAAAAGTAAGAGGAACACACATATAAATGCTGACTCTTCAGTAATTTTCCTAGATTCCATTTTGAAAGACGATGCAGAGAGGAA AAGCAAAACCAGAAATATCTCCTTCCTAAAACCTTCTCTAGAGACAGAGAATAGTGGGTTGCCCCCTGGGGCTACTGACAGTGGATCTTCTTGGAGGAAGCCTGAGGACCAAGAAGAAGTTGGTGAGG AACCCAAGAACCAAGTGCTGAGAGAGAAATACAAACGGGTGAGCGACAGAATATCTTTTTGGGAAGGAGGCAAAGCTGGTGCTAAGTTAAAGGCACCACAGCCCGCATCTTCTTGTAGCCAGGAGTCA TCTTCAACTAAAGCATACCAGCCCGTGAAGTCACAAGTCATGTCCCTGGGCAGTTTATCTTTAGGCCAGAGTGACTATAGTCAAGTCACAGCTAAACATGGGGTCTTTGATGGGGATGACCAAACACC TCGTCTCGCTAGTTCTTCTTCCTCAAATAAACCTGAAACAACCGGGTCCCCAATATCAGGTCTATCCAAAAACCACCCTTCAGGTAACCAGTTCGGTAAAGTAACTCTACCTCAAACTATGGAGAATG AAACACACCCTTCTTTGGAGAAAGACAGATTTCTGATTGATAAATCAAATGGCAACTTCAAAGTTCTGTCTCTAAGAGAAAGGATGGATGAACGCAATACAGAACACGTCTATAGTCACTCTCAGTTT GAGAATCTGAGGAAGTTTTGGGGCCTGGGAGCTGACGGAAACAGTAAACATAGCGATGGGAATAATACTGCTACAAACAAACAAACGTCTGTGCCGTCGAACAGACAGAAATCCAAGGAGTTTAACAC CGTGAACTTATCAAGTGAAAAGACCCCTGAAGTAGAAGAAGGAAGACATTTAAGGCAGGGAAATGTTGGAGCTGCAGAAGAGATGGAGAAATTAAACTTAAAGTGCAGGCTTCCAGCACCACCAGACG AAACCAAATTTCCACAGAAAACACCCCAAAAGTTCACTTATCCGTTGGTAGGAAATGAGCCTTCGAAGGAAGATGTAGGAAAAAATACAGAATGCTTGGTTACCCCAGTGACTGAAAAGGCTTGCTCG GATCAAGAGATTCAAGAATCCATAGTGAAAACAAGTGTTTTGCCTAAAGTCTCTACAGACACGTTCAAGGACAGGGTACAGAAGTTAGTGGCAGAAGCCACATCACCAGCAGGCCAGACTTCTGGCAA GGAAGTTCATGAGCAGCAAGCGCTCAAAGTCGGTGCTTCTGAAAATGGGGCATGGCCTCAAAACAAAAGTTTTGTCAAGGATGAGGAGGAACTCACAGGGGTCAAGAAGAGCACCAAAGAGCTCCAAA GAAGGATTCCACAGGACTGTAGTGTGGACAAACTCCTGAAGGAAGCAACTGGAACTCCGTCGAGTCCCTTGCAATCTCTGCAGGAACCGGTTATGACTAGACCCTCCTCCCCACCTAAAGAGGACCTA TTGTTTAAAAAGTGGATAAGAGAGAATCACAGTCCTTCAGCAGATCAGAGAGAGAGAACAGCTCCTTCCCCACAGGGTGTTGAAACTTTGGCAGGTACAGATTTCACCTCGAAGGCCAAACATTGTAA CACAGAAGGGATGCTTCAGTTGACTGCAGAAGGGTCTCCTCCATTGGCTCAGCCTTCCCAGTCTTTTGAGGGAGTTTCCAGTCCTCCAGCAGATGTGTCTTTATCTTGGAATGCTCCTCTTCTGTCCC AGGATAGCACCTTGTCTTCTCAGAGGGAAATTTCTGAGGCTATAGAGAAAGTTGTTCTTCCCTCCAAACCAGCAATGACCGATATAAATGCTGTATTGCAGAAGCTACTTAGAGAAGCTGGAGAAGTA GACACCAAGCTCCCTGAAAGACCCTTAAGCCCTCAGAGAGTGAGTTCTGTGTGGGCTGCTCCAGACCCTGTTGGTCCAAATGAGGACTCCCATTCTTCTTACCCGGTTCCTGATACAACTCATGAAGG CAGATCTGCTAGAATGGCACCATCAGCACATGCCACTACGTCACCTACTTATACTGTGACTCGGTATGGTCAGGAGCTACTTCAGGAAGTGGCAGAGACAGTGAGGGAGACGATCATTCAGCCTAAGC CAGAGTGCCCTGAATTCAGGGCTGCCTTGGAAAAACTACGAAAGGAAACACTGCAAACTTCCCTGTCAAAAGACGACAAGAATACAGTGACTATTTCCCCATCAGCCTTAACAGGTAGTTGTGAGACG TCCCATCAGCTTGCTTTTGAATTCCATCCTACAGAAATACAAGAAACTGTAGAGAAGGCTGAGGCTCCATCAGTTACTGAGAGCATTTTTGATGTTGGTCTTGAGAAACTTCTTAAAGAGATGTCCGA AGGGCCTCGTCAGCTCCAGCTGACAAGAGACATTTTGGAGAAGCAGACTTCACAGGCAGAGCAAGCAGGGCTCATGGGAGAAACACCCCATCCTTTTTTGGATGACTCAGGAGCCTCTAAAATGAACT TTGCAAGTAGTGGTTTGGAATCTCAAGTCAGCCCGTGTGATAAACAATTAGGAGGAGATGAAGCTGTCACTGGTCAATTGATAGATGTCCAGGGTTACGCAGGTGGGTTTGGGGTCTCTGAATGCCCC CAACCTTATGAAGACCATAAAAGAGAGGACGTTGAAACTGTGCTATTTGTAGAGGACAAAGGCAGAGAAAAGGTTATTGCAGAAGCAACACGGGCTCCCCAGAAACCAGGCTTTGAAGAAGCTCCTAA AGAAATGAGGGTGTCCAGAAATAAGCGCTCCATTGTTCTCCTGGAAACAAAAGGAAAGGCTACAGAAACAAGCACAGTTAAATCCGAACTAGCAACAGCATATAAGAGACAAGAGAAAGAACAAGGAC CAGAGGCATGCTCTGAATCTGAGTTTTCAGATGGGAACACCAGCTCTAACAGGGAGAGCTGGAGAAATACCTCCAGTTCAGAAGAAGAACACAGCCCTGTTTTGAAAACTTTGGAAAGGAGAGCTGCT AGGAAAATACCTTCCAAAAGTCTGGAAGACATTCCATCAGATTCATCAAATCAAGCAAAAGTAGATAATCTGCCTGAAGAATTAGTCCGTAGTGCTGAAGATGATCAAAAAGCAGACCAGGACCCAGA TACAAATGAATGTATACCAGGAATTTCCACAGTGCCTTCACTGCCTGATAATCCGTTTTCCCACCCTGACAAACTCAAAAGGATGAGCAAGTCCGTGCCAGCATTTCTTCAAGATGAGAGCGATGACA GAGAAACAGACACAGCATCAGAGAGCAGCTACCAGCTCAGGAGATACAAGAAGAGCCCCAGCTCATTAACCAATCTTAGCAGCTCCTCTGGCATGACGTCCTTGTCCTCTGCGAGTGGCAGTGTGATG AGCGTTTACAGCGGAGACTTTGGCAACCTGGAAGTGAAAGGAAGTGTGCAGTTTGCAATCGACTACGTGGAGTCCCTGAAAGAGCTACATGTGTTTGTGGCCCAGTGTAAGGACTTAGCAGCAGCAGA TGCTAAGAAACAGCGCTCAGACCCATATGTAAAGACCTATCTTCTACCAGACAAAGGCAAAATGGGCAAGAAGAAGACCCTTGTAGTGAAGAAGACCTTGAATCCTGTATACAACGAGATATTGCGGT ATAAAATTGAAAGGCAAGTCTTAAAGACACAGAAGTTGAACCTGTCTGTTTGGCATCGGGATACGTTTAAGCGCAACAGCTTTCTGGGGGAGGTAGAACTTGACCTCGAAACATGGGACTGGGACAGC AAACAGAACAAACAACTGAAGTGGTACCCGCTGAAGAGGAAGACAGCACCAGTTGCCCTTGAGACAGAAAACAGAGGTGAAATGAAGCTAGCTCTCCAATATGTTCCGGAGCCAAGCCCTGGCAAAAA GCTTCCTACTACTGGAGAAGTGCACATCTGGGTGAAGGAATGCCTTGACCTCCCACTGCTGAGGGGGAGCCACCTAAATTCTTTTGTTAAGTGTACCATCCTTCCAGATACCAGTAGAAAAAGTCGCC AGAAGACAAGAGCTGTAGGAAAAACCAGCAACCCCGTCTTCAACCATACCATGGTGTATGATGGGTTCAGGCCTGAAGATCTGATGGAAGCCTGTGTAGAACTCACAGTCTGGGACCATTATAAACTA ACCAACCAGTTTCTGGGAGGTCTCCGGATCGGCTTTGGAACAGGGAAAAGCTACGGGACTGAAGTGGATTGGATGGACTCTACCTCTGAGGAAGCTGCTCTCTGGGAGAAGATGGTAAACTCTCCCAA CACTTGGGTTGAAGCAATGCTGCCCCTCAGGATGCTTCTCATCGCCAAGATTTCCAAGTGATCTTAGTCAGCGGATTCCACCATCAAAAGCTACTCCCCGGGGGGAGCTACTCCCCGGGGGGATCTGA ACTTGAGCTGACGTCGTGCACAGATATCCTCTCCCATCGTCACTAATGACAACTATGAAGCATGCTCAACTTAATCTGCACGCATTCCTTTGCTTGCATGGCTCAAGGGAACTAAACCATGACAAGAT GTACAGCCCAGAAGTGCGATGTGATGCCAACATTCACGGAGACAACTGAACGAGCTAGGAAAACTGAACTGTTGCTCCCACACCAAAGAAAAAGCTAGCTTTACATGTTTCGTACCACAATCTGTGTT GCAGTTCAGGCCTGCCTTTTGGTTATTAAAATGCTTGCTGGGCATATAAATAGGAAGGTTACGAGCAAAAGGACAAGGATACTCCTGGGCTGGGGCAGAGAGAGGAAGGACAGAGGTGATGACAACGA CCTACATAATATGACAACTATTTACTTAGTAACCTCTAATGAAACATTGAATTCCATCTCAGGGCAGTAAGACTGACTTCACTGCTCATAAATCTGCCTTGAGAAACCCCCACACACCCCGACTCCTA TAACGTCACCTTTCTCAGTCTCAAACGGACTTTGGTGCCACCTACTGGCTGCATATGGAATTCAGCTCTTGGCTTATTTTGGCTTCATTTTTGCTAAAACGGGTGGCAAGTGTGTATTTTATAAGACT ATGCTAAAATATTGCATATAATGATGGTTTTTCTTATGATTTTACTATACGGAAACAGCATAATAGTCACAGATATGCTTTGCTACAAAGTTTTAATCGAAATATAAATTGCTCAACTGTATTGAACT TCCTATGTATAATTTTCAGAAGGTATTTTGTAAAAACCCTTAGAATAAATTATCATGACTTAAATTGTATTGGTAGTTTATCCTACCTTCTTAGATTTAAAAACAATACGTTGTATTAGGAATCCTAA AATATAAATTCTCTGGTA
hide sequence
RefSeq Acc Id:
XM_039082402 ⟹ XP_038938330
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,405 - 153,791,758 (+) NCBI mRatBN7.2 1 144,272,872 - 144,379,310 (+) NCBI
RefSeq Acc Id:
XM_039082407 ⟹ XP_038938335
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,404 - 153,791,758 (+) NCBI mRatBN7.2 1 144,272,870 - 144,379,310 (+) NCBI
RefSeq Acc Id:
XM_039082411 ⟹ XP_038938339
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,403 - 153,791,758 (+) NCBI mRatBN7.2 1 144,272,870 - 144,379,310 (+) NCBI
RefSeq Acc Id:
XM_039082420 ⟹ XP_038938348
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,409 - 153,791,758 (+) NCBI mRatBN7.2 1 144,272,873 - 144,379,310 (+) NCBI
RefSeq Acc Id:
XM_039082423 ⟹ XP_038938351
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,865 - 153,791,758 (+) NCBI mRatBN7.2 1 144,273,342 - 144,379,310 (+) NCBI
RefSeq Acc Id:
XM_039082427 ⟹ XP_038938355
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,865 - 153,791,758 (+) NCBI mRatBN7.2 1 144,273,342 - 144,379,310 (+) NCBI
RefSeq Acc Id:
XM_039082431 ⟹ XP_038938359
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,865 - 153,791,758 (+) NCBI mRatBN7.2 1 144,273,337 - 144,379,310 (+) NCBI
RefSeq Acc Id:
XM_063266999 ⟹ XP_063123069
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,686,027 - 153,791,758 (+) NCBI
RefSeq Acc Id:
XM_063267013 ⟹ XP_063123083
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,686,027 - 153,791,758 (+) NCBI
RefSeq Acc Id:
XM_063267027 ⟹ XP_063123097
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,686,004 - 153,791,758 (+) NCBI
RefSeq Acc Id:
XM_063267036 ⟹ XP_063123106
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,999 - 153,791,758 (+) NCBI
RefSeq Acc Id:
XM_063267042 ⟹ XP_063123112
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 153,685,866 - 153,791,758 (+) NCBI
RefSeq Acc Id:
XP_008757873 ⟸ XM_008759651
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6AM63 (UniProtKB/TrEMBL)
- Sequence:
MIDLSFLTEEEQDAILKVLQRDAALKRAEEERVRHLPEKIKDDQQLKNMSGQWFYEAKAKRHKDKIHGADIIRASMRRKRLPAAAEQKKDTAMRTKESWVNNVNKDASLPPELAVVEEPADDTGPAGP SSSVVDPASSAIERSQENTRTPAVSLPKQRKNPFDSLETPEDLSSQQTKTKQSKTGKAGLFQISKEGGLSESKEKPSIPDMSCQKSEKPKQPVSMETENASLIKAPIPKARKLIYKSNDLKNDDYLSF AGQRRDSLNARGTPRGILKRNSSSSSTDSETLRLNYNLDPKSKILSPGLTIHERISEKEHSLDDDSCTNSLEPLKHVRFSAVKNDLPQSPRPVLGQEVGEFTVLESDRLQNGTEDTGDIDEFQDHPEF SHRKPLSLYQSVTNPRISERETEQPMSSGSIPSEEISCHSDILPTRPQCVESSSIISEQDKSSHFTKLQSEMSKSPEDELTQCVEPEPSQTSDHSFRDHRQGKPLLTALTDQTASPVGPCATEIRKTT DDSISKVLDWFNRSSHTEDSTSTLQHLQGLDLREQTDSRAQISNTLMTDNMSLKGDDTKVPASTTTKVKPVRPDSTFQEEGDVLASESCRDSDALLKSNSEDLSQQGTLKKGPDTLQRFERYRIPSHK NENMGDSQGSESTGEGVGTLPADSDYLLRPLKRSDSEEAPWNTTHPSSLGKGKTKFHVPQKSKRNTHINADSSVIFLDSILKDDAERKSKTRNISFLKPSLETENSGLPPGATDSGSSWRKPEDQEEV GEEPKNQVLREKYKRVSDRISFWEGGKAGAKLKAPQPASSCSQESSSTKAYQPVKSQVMSLGSLSLGQSDYSQVTAKHGVFDGDDQTPRLASSSSSNKPETTGSPISGLSKNHPSGNQFGKVTLPQTM ENETHPSLEKDRFLIDKSNGNFKVLSLRERMDERNTEHVYSHSQFENLRKFWGLGADGNSKHSDGNNTATNKQTSVPSNRQKSKEFNTVNLSSEKTPEVEEGRHLRQGNVGAAEEMEKLNLKCRLPAP PDETKFPQKTPQKFTYPLVGNEPSKEDVGKNTECLVTPVTEKACSDQEIQESIVKTSVLPKVSTDTFKDRVQKLVAEATSPAGQTSGKEVHEQQALKVGASENGAWPQNKSFVKDEEELTGVKKSTKE LQRRIPQDCSVDKLLKEATGTPSSPLQSLQEPVMTRPSSPPKEDLLFKKWIRENHSPSADQRERTAPSPQGVETLAGTDFTSKAKHCNTEGMLQLTAEGSPPLAQPSQSFEGVSSPPADVSLSWNAPL LSQDSTLSSQREISEAIEKVVLPSKPAMTDINAVLQKLLREAGEVDTKLPERPLSPQRVSSVWAAPDPVGPNEDSHSSYPVPDTTHEGRSARMAPSAHATTSPTYTVTRYGQELLQEVAETVRETIIQ PKPECPEFRAALEKLRKETLQTSLSKDDKNTVTISPSALTGSCETSHQLAFEFHPTEIQETVEKAEAPSVTESIFDVGLEKLLKEMSEGPRQLQLTRDILEKQTSQAEQAGLMGETPHPFLDDSGASK MNFASSGLESQVSPCDKQLGGDEAVTGQLIDVQGYAGGFGVSECPQPYEDHKREDVETVLFVEDKGREKVIAEATRAPQKPGFEEAPKEMRVSRNKRSIVLLETKGKATETSTVKSELATAYKRQEKE QGPEACSESEFSDGNTSSNRESWRNTSSSEEEHSPVLKTLERRAARKIPSKSLEDIPSDSSNQAKVDNLPEELVRSAEDDQKADQDPDTNECIPGISTVPSLPDNPFSHPDKLKRMSKSVPAFLQDES DDRETDTASESSYQLRRYKKSPSSLTNLSSSSGMTSLSSASGSVMSVYSGDFGNLEVKGSVQFAIDYVESLKELHVFVAQCKDLAAADAKKQRSDPYVKTYLLPDKGKMGKKKTLVVKKTLNPVYNEI LRYKIERQVLKTQKLNLSVWHRDTFKRNSFLGEVELDLETWDWDSKQNKQLKWYPLKRKTAPVALETENRGEMKLALQYVPEPSPGKKLPTTGEVHIWVKECLDLPLLRGSHLNSFVKCTILPDTSRK SRQKTRAVGKTSNPVFNHTMVYDGFRPEDLMEACVELTVWDHYKLTNQFLGGLRIGFGTGKSYGTEVDWMDSTSEEAALWEKMVNSPNTWVEAMLPLRMLLIAKISK
hide sequence
Ensembl Acc Id:
ENSRNOP00000048585 ⟸ ENSRNOT00000045048
Ensembl Acc Id:
ENSRNOP00000039142 ⟸ ENSRNOT00000042163
RefSeq Acc Id:
XP_038938335 ⟸ XM_039082407
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_038938339 ⟸ XM_039082411
- Peptide Label:
isoform X4
RefSeq Acc Id:
XP_038938330 ⟸ XM_039082402
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I5Y7C8 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038938348 ⟸ XM_039082420
- Peptide Label:
isoform X5
RefSeq Acc Id:
XP_038938359 ⟸ XM_039082431
- Peptide Label:
isoform X8
RefSeq Acc Id:
XP_038938351 ⟸ XM_039082423
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038938355 ⟸ XM_039082427
- Peptide Label:
isoform X7
RefSeq Acc Id:
NP_001101962 ⟸ NM_001108492
- UniProtKB:
A0A8I6AM63 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000096638 ⟸ ENSRNOT00000114461
Ensembl Acc Id:
ENSRNOP00000077270 ⟸ ENSRNOT00000103814
RefSeq Acc Id:
XP_063123112 ⟸ XM_063267042
- Peptide Label:
isoform X8
RefSeq Acc Id:
XP_063123106 ⟸ XM_063267036
- Peptide Label:
isoform X7
RefSeq Acc Id:
XP_063123097 ⟸ XM_063267027
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_063123083 ⟸ XM_063267013
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_063123069 ⟸ XM_063266999
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I5Y7C8 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Sytl2
synaptotagmin-like 2
Sytl2_predicted
synaptotagmin-like 2 (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Sytl2_predicted
synaptotagmin-like 2 (predicted)
Symbol and Name status set to approved
70820
APPROVED